Skip to main content

EL

Stock
Consumer Staples
Household & Personal Products

Performance overview

EL Price
Price Chart

Forward-looking statistics

Beta
1.42
Risk
48.34%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Estee Lauder is a leader in the global prestige beauty market, participating across skin care (52% of 2023 sales), makeup (28%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estee Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 28% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 33% from Asia-Pacific. Estee Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

Company info

SectorConsumer Staples
IndustryHousehold & Personal Products
Employees47K
Market cap$43.2B

Fundamentals

Enterprise value$35.8B
Revenue$14.8B
Revenue per employee—
Profit margin-5.89%
Debt to equity215.93

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)-$2.42
Dividend per share$1.40
Revenue per share$41.09
Avg trading volume (30 day)$410M
Avg trading volume (10 day)$536M
Put-call ratio—

Macro factor sensitivity

Growth+1.1
Credit+2.9
Liquidity-0.6
Inflation-1.5
Commodities-0.0
Interest Rates-1.3

Valuation

Dividend yield1.58%
PEG Ratio32.86
Price to sales2.16
P/E Ratio32.86
Enterprise Value to Revenue2.42
Price to book7.35

Upcoming events

Next earnings dayAugust 20, 2025
Next dividend day—
Ex. dividend dayMay 30, 2025

News

Equity Lifestyle Properties (ELS) Q2 FFO Match Estimates

Equity Lifestyle Properties (ELS) came out with quarterly funds from operations (FFO) of $0.69 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.66 per share a year ago.

Zacks Investment Research (July 21, 2025)
How Will Celsius Leverage Its Energy Drink Market Share in 2025?

CELH rides rising lifestyle trends with bold innovations, shelf gains and the Alani Nu boost driving energy market share.

Zacks Investment Research (July 21, 2025)
Will Estee Lauder (EL) Beat Estimates Again in Its Next Earnings Report?

Estee Lauder (EL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research (July 21, 2025)
EXEL vs. ARGX: Which Stock Should Value Investors Buy Now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Exelixis (EXEL) and argenex SE (ARGX). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research (July 21, 2025)
Exelixis (EXEL) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Exelixis (EXEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research (July 21, 2025)
What Analyst Projections for Key Metrics Reveal About TE Connectivity (TEL) Q3 Earnings

Get a deeper insight into the potential performance of TE Connectivity (TEL) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks Investment Research (July 21, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free